Sunosi Criteria Added to Central Nervous System Stimulants Clinical Prior Authorization Starting Mar

Sunosi Criteria Added to Central Nervous System Stimulants Clinical Prior Authorization Starting March, 9 2020

FirstCare implemented the clinical prior authorization criteria for Sunosi (solriamfetol) on March, 9 2020. All clinical edit criteria can be found here.

The criteria is part of the Central Nervous System Stimulants clinical prior authorization.  The drugs Provigil and Nuvigil are already part of this clinical prior authorization.

Send to a Friend

* Required field

Captcha The math problem above is intended to reduce spam.